2022 in numbers
2022 has been a promising year for patients suffering from gastroesophageal reflux disease (GERD) as well as clinicians and professionals working in the area of gastrointestinal disease, e-health and artificial intelligence. In May, we launched collaborative eCAP project to make reflux disease diagnostics & care accessible to all, improve patient outcomes and tackle healthcare inefficiencies. As the year is coming to a close, we reflected on the work done.
How did 2022 look in numbers for eCAP consortium?
ü€4.75 million secured in funding from the European Commission through Horizon Europe
ü 9 world-leading experts involved in the project Advisory Committees
ü 12 deliverables submitted
ü 1 work package completed
ü 106+ pages of meeting minutes produced
What is the plan for 2023?
ü Develop the first eCAP capsule prototype
ü Meet clinicians and stakeholders in Kenya
ü Stay curious and keep learning from the cross-disciplinary collaboration between 10 great partners
We wish you healthy and peaceful holidays, a successful end of the year and an even better 2023!